Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Northwest Biotherapeutics (NWBO) Receivables - Other (2016)

Northwest Biotherapeutics' Receivables - Other history spans 5 years, with the latest figure at $700000.0 for Q3 2016.

  • Quarterly results put Receivables - Other at $700000.0 for Q3 2016, down 41.67% from a year ago — trailing twelve months through Sep 2016 was $700000.0 (down 41.67% YoY), and the annual figure for FY2015 was $1.2 million, changed.
  • Receivables - Other for Q3 2016 was $700000.0 at Northwest Biotherapeutics, down from $1.0 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $4.8 million in Q3 2012 to a low of $700000.0 in Q3 2016.
  • The 4-year median for Receivables - Other is $1.2 million (2015), against an average of $2.0 million.
  • The sharpest move saw Receivables - Other crashed 54.29% in 2015, then tumbled 41.67% in 2016.
  • Year by year, Receivables - Other stood at $4.8 million in 2012, then plummeted by 45.31% to $2.6 million in 2014, then crashed by 54.29% to $1.2 million in 2015, then plummeted by 41.67% to $700000.0 in 2016.
  • According to Business Quant data, Receivables - Other over the past three periods came in at $700000.0, $1.0 million, and $1.0 million for Q3 2016, Q2 2016, and Q1 2016 respectively.